https://scholars.lib.ntu.edu.tw/handle/123456789/539527
標題: | Literature review of the epidemiology of influenza B disease in 15 countries in the Asia-Pacific region | 作者: | Jennings L. Huang Q.S. Barr I. PING-ING LEE Kim W.J. Buchy P. Sanicas M. Mungall B.A. Chen J. |
關鍵字: | Asia-Pacific; epidemiology; influenza B; literature review; seasonality; vaccine mismatch | 公開日期: | 2018 | 出版社: | Blackwell Publishing Ltd | 卷: | 12 | 期: | 3 | 起(迄)頁: | 383-411 | 來源出版物: | Influenza and other Respiratory Viruses | 摘要: | Influenza control strategies focus on the use of trivalent influenza vaccines containing two influenza A virus subtypes and one of the two circulating influenza type B lineages (Yamagata or Victoria). Mismatches between the vaccine B lineage and the circulating lineage have been regularly documented in many countries, including those in the Asia-Pacific region. We conducted a literature review with the aim of understanding the relative circulation of influenza B viruses in Asia-Pacific countries. PubMed and Western Pacific Region Index Medicus were searched for relevant articles on influenza type B published since 1990 in English language for 15 Asia-Pacific countries. Gray literature was also accessed. From 4834 articles identified, 121 full-text articles were analyzed. Influenza was reported as an important cause of morbidity in the Asia-Pacific region, affecting all age groups. In all 15 countries, influenza B was identified and associated with between 0% and 92% of laboratory-confirmed influenza cases in any one season/year. Influenza type B appeared to cause more illness in children aged between 1 and 10 years than in other age groups. Epidemiological data for the two circulating influenza type B lineages remain limited in several countries in the Asia-Pacific, although the co-circulation of both lineages was seen in countries where strain surveillance data were available. Mismatches between circulating B lineages and vaccine strains were observed in all countries with available data. The data suggest that a shift from trivalent to quadrivalent seasonal influenza vaccines could provide additional benefits by providing broader protection. © 2017 The Authors. Influenza and Other Respiratory Viruses Published by John Wiley & Sons Ltd. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85043345472&doi=10.1111%2firv.12522&partnerID=40&md5=f22ed8a47932d607764bffa60100cba8 https://scholars.lib.ntu.edu.tw/handle/123456789/539527 |
ISSN: | 1750-2640 | DOI: | 10.1111/irv.12522 | SDG/關鍵字: | influenza vaccine; influenza vaccine; Australia; Cambodia; China; comorbidity; controlled study; groups by age; human; immunity; Indonesia; influenza A; Influenza A virus (H1N1); Influenza A virus (H3N2); influenza B; influenza vaccination; laboratory test; Laos; major clinical study; Malaysia; morbidity; Myanmar; New Zealand; Note; Pacific islands; Philippines; priority journal; seasonal influenza; Singapore; South Korea; Southeast Asian; Taiwan; Viet Nam; virus strain; Asia; child; classification; climate; influenza; Influenza B virus; isolation and purification; preschool child; season; standards; United States; vaccination coverage; Asia; Child; Child, Preschool; Climate; Humans; Influenza B virus; Influenza Vaccines; Influenza, Human; Pacific States; Seasons; Vaccination Coverage |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。